MedTrace Logo

Drug-Related Problems and Healthcare Utilization Post-Hospital Discharge

NCT01806038 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2014-11-13

No results posted yet for this study

Summary

The goal of this study is to investigate whether pharmacist provided counseling and medication dispensing at the patient's bedside can provide better outcomes than the current discharge process at Duke University Hospital. This study will be single-site, prospective, randomized, cohort study. Patients who meet the inclusion and exclusion criteria, and provide consent will be included in this study.

Conditions

  • Drug Related Problems Post Hospital Discharge
  • Healthcare Utilization
  • Discharge Medication Counseling

Interventions

OTHER

RPh Counseling + Outpatient Med Dispensing at Discharge

On the day of discharge, a pharmacist will perform a chart review and medication reconciliation on all patients' discharge medications (for patients randomized to the intervention arm). Any medication discrepancies will be addressed with the patient's primary care team. At the time of discharge, the patient will receive his/her discharge medications dispensed from the Duke Outpatient Pharmacy, along with medication counseling by a licensed pharmacist

OTHER

Discharge Med Dispensing Plus Counseling - Current Practice

At hospital discharge, patients will receive standard discharge procedures and obtain discharge medications per their usual process

Sponsors & Collaborators

Principal Investigators

  • Paul W. Bush, PharmD, MBA · Department of Pharmacy, Duke University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-03-31
Primary Completion
2014-04-30
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01806038 on ClinicalTrials.gov